Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Two mouthwashes for gum disease: CHX 0.2% versus CHX 0.12% + CPC

Official title: Comparative Clinical Efficacy and Microbiological Effects of Two Oral Antiseptics Used as an Adjuvant in the Treatment of Severe Periodontitis

Run by The University of Hong Kong · NCT06967402 · Data updated 2026-11-12

This study tests whether a lower-concentration chlorhexidine mouthwash with CPC works as well as a standard chlorhexidine mouthwash as an extra treatment for periodontitis.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorThe University of Hong Kong
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Hong Kong)
StatusRecruiting
StartedNovember 20, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedJune 23, 2026
Trial IDNCT06967402 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with generalized stage II–III periodontitis, at least 6 evaluable teeth per quadrant, and no recent antibiotics or CHX/CPC exposure.

Probably not a fit

Patients with more advanced disease, significant comorbidities, or non-compliance may not benefit or could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with generalized stage II–III periodontitis will use a mouthwash as an adjunct to initial periodontal therapy. The study compares CHX 0.2% (control) to CHX 0.12% plus CPC 0.05% (experimental) over about 2 months, assessing inflammation, plaque, and microbiology, as well as patient-reported outcomes. Primary outcome is changes in full mouth bleeding on probing at 2 months after 21 days of daily use. Secondary outcomes include gingival indices, plaque indices, pocket depth, clinical attachment level, microbiological changes, tongue coating and staining, taste irritation, and safety signals.

Why it matters

Potential benefit: If non-inferiority is demonstrated, the lower-concentration mouthwash could reduce side effects while maintaining effectiveness.

How similar studies have gone: Previous antiseptic mouthwashes have shown plaque and inflammation reduction; this study tests a novel combination at lower CHX concentration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consenting patients with at least 6 evaluable teeth in each quadrant, including minimum 1 molar and 1 premolar.
* Generalized stage II-III periodontitis patients.
* Baseline BOP \> 25%.
* No known allergy or adverse effects to CHX or CPC
* Non-smokers, non-orthodontic patients, no concurrent or past antibiotics/medication known to affect periodontal status (i.e. calcium antagonists, phenytoin)/anti-inflammatory therapy (i.e. NASIDs) in the last 3 months, pregnant/breastfeeding, compliance to study procedures.
* ASA class I-II patients.
* Either non-diabetic or with controlled diabetes (HbA1C\<7).
* Normal/Elevated blood pressure (AHA - Systolic \<130mmHg; Diastolic \<80mmHg).
* No radiation/chemotherapy in the past 5 years
* No immunosuppression including drug induced immunosuppression.
* No participation in other clinical studies in the last 4 weeks.
* No administration of CHX or CPC in the last 3 months
* No periodontal treatment in the last 3 months.

Exclusion Criteria:

* Unable to provide written consent.
* Non-compliant study procedures.
* Patients with medical (including psychiatric) and pharmacotherapeutic histories that, in the investigator's opinion, may compromise the protocol.
* Patients requiring antibiotics prophylaxis for dental procedures.
* Patients with self-reported pregnancy or patients who are breastfeeding.
* Patients with history of use of systemic antibiotics, in combination with any form of periodontal treatment, within the past 3 months.
* Patients with uncontrolled endocrine disease.
* Patients who are not compliant with the review protocol, leading to deviation of more than 1 week.
* Patients requiring the admission of systemic antibiotics, in combination with any form of dental treatment, during the study period.

Where it's running

  • HKU Faculty of Dentistry, IAD - Clinical Research Centre
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.